Skip to main content

Part of the book series: SpringerBriefs in Pharmaceutical Science & Drug Development ((BRIEFSPSDD))

  • 3440 Accesses

Abstract

In recent decades, we in academia have focused on advancing scientific understanding through basic research and counted on the biopharmaceutical industry to translate promising discoveries into new therapeutics. Given the recent developments, however, this paradigm needs to change. Pharmaceutical companies have drastically cut their research budgets and basic research staffs to decrease costs and improve short-term profits. Additionally, the number of biotechnology venture funds has contracted, especially those that invest in new biotechnology start-up companies. As a result, we can expect that fewer novel drug programs will originate in the biopharmaceutical sector. Academic inventors can and should step in to fill this gap in the discovery pipelines. But we often lack the expertise and resources to advance our projects through this applied science stage of drug discovery and development. This chapter introduces the process of drug development and highlights some of the important first steps: understanding the clinical needs, developing a target product profile (which defines the new drug’s essential characteristics), and adopting a project management approach. These essential steps not only increase the likelihood of success, but can also help decrease both the cost and time required to accomplish our goal. Translating discoveries from bench to bedside is a challenging, but incredibly rewarding process, allowing us to advance scientific discovery and ensure that our government-funded research translates into improved health for our society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Frearson JA, Wyatt PG, Gilbert IH, Fairlamb AH (2007) Target assessment for antiparasitic drug discovery. Trends Parasitol 23(12):589–595. doi:10.1016/j.pt.2007.08.019

    Article  PubMed  CAS  Google Scholar 

  2. Nwaka S, Ramirez B, Brun R, Maes L, Douglas F, Ridley R (2009) Advancing drug innovation for neglected diseases—criteria for lead progression. PLoS Negl Trop Dis 3(8):e440. doi:10.1371/journal.pntd.0000440

    Article  PubMed  Google Scholar 

  3. Kennedy A (2008) Pharmaceutical project management, vol 182, 2nd edn, Drugs and the pharmaceutical sciences. Informa Healthcare, New York

    Google Scholar 

  4. Linberg SE (2006) Expediting drugs and biologics development, 3rd edn. Parexel International Corporation, Waltham, MA, USA

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Daria Mochly-Rosen , Daria Mochly-Rosen , Kevin Grimes or Kevin Grimes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mochly-Rosen, D., Grimes, K. (2014). Getting Started. In: Mochly-Rosen, D., Grimes, K. (eds) A Practical Guide to Drug Development in Academia. SpringerBriefs in Pharmaceutical Science & Drug Development. Springer, Cham. https://doi.org/10.1007/978-3-319-02201-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-02201-7_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-02200-0

  • Online ISBN: 978-3-319-02201-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics